Works matching AU Ansell, Stephen

Results: 256
    1
    2

    The Lymphomas.

    Published in:
    2006
    By:
    • Ansell, Stephen M.
    Publication type:
    Book Review
    3

    Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer.

    Published in:
    Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01848-z
    By:
    • Leon-Ferre, Roberto A.;
    • Whitaker, Kaitlyn R.;
    • Suman, Vera J.;
    • Hoskin, Tanya;
    • Giridhar, Karthik V.;
    • Moore, Raymond M.;
    • Al-Jarrad, Ahmad;
    • McLaughlin, Sarah A.;
    • Northfelt, Donald W.;
    • Hunt, Katie N.;
    • Conners, Amy Lynn;
    • Moyer, Ann;
    • Carter, Jodi M.;
    • Kalari, Krishna;
    • Weinshilboum, Richard;
    • Wang, Liewei;
    • Ingle, James N.;
    • Knutson, Keith L.;
    • Ansell, Stephen M.;
    • Boughey, Judy C.
    Publication type:
    Article
    4
    5

    Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01256-w
    By:
    • Breen, William G.;
    • Hathcock, Matthew A.;
    • Young, Jason R.;
    • Kowalchuk, Roman O.;
    • Bansal, Radhika;
    • Khurana, Arushi;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Villasboas Bisneto, Jose C.;
    • Wang, Yucai;
    • Ansell, Stephen M.;
    • Peterson, Jennifer L.;
    • Johnston, Patrick B.;
    • Lester, Scott C.;
    • Lin, Yi
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    T-cell phenotype including CD57<sup>+</sup> T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00899-3
    By:
    • Yang, Zhi-Zhang;
    • Kim, Hyo Jin;
    • Wu, Hongyan;
    • Tang, Xinyi;
    • Yu, Yue;
    • Krull, Jordan;
    • Larson, Daniel P.;
    • Moore, Raymond M.;
    • Maurer, Matthew J.;
    • Pavelko, Kevin D.;
    • Jalali, Shahrzad;
    • Pritchett, Joshua C.;
    • Mudappathi, Rekha;
    • Wang, Junwen;
    • Villasboas, Jose C.;
    • Mondello, Patrizia;
    • Novak, Anne J.;
    • Ansell, Stephen M.
    Publication type:
    Article
    12

    Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00895-7
    By:
    • Breen, William G.;
    • Young, Jason R.;
    • Hathcock, Matthew A.;
    • Kowalchuk, Roman O.;
    • Thorpe, Matthew P.;
    • Bansal, Radhika;
    • Khurana, Arushi;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Bisneto, Jose Villasboas;
    • Wang, Yucai;
    • Ansell, Stephen M.;
    • Peterson, Jennifer L.;
    • Johnston, Patrick B.;
    • Lester, Scott C.;
    • Lin, Yi
    Publication type:
    Article
    13

    Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00777-4
    By:
    • Acosta-Medina, Aldo A.;
    • Johnson, Isla McKerrow;
    • Bansal, Radhika;
    • Hathcock, Matthew;
    • Kenderian, Saad J.;
    • Durani, Urshila;
    • Khurana, Arushi;
    • Wang, Yucai;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Bennani, N. Nora;
    • Johnston, Patrick B.;
    • Ansell, Stephen M.;
    • Lin, Yi;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    14
    15

    PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
    By:
    • Desai, Sanjal H.;
    • Pederson, Levi;
    • LaPlant, Betsy;
    • Mwangi, Raphael;
    • Maurer, Matthew;
    • Young, Jason R.;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Cerhan, James R.;
    • Feldman, Andrew;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    16
    17

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    18

    Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
    By:
    • Desai, Sanjal H.;
    • LaPlant, Betsy;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    19

    Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
    By:
    • Arushi Khurana;
    • Mwangi, Raphael;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Strouse, Christopher;
    • Link, Brian K.;
    • Wang, Yucai;
    • King, Rebecca L.;
    • Macon, William R.;
    • Villasboas, J. C.;
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    20
    21

    Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
    By:
    • Gile, Jennifer J.;
    • Lopez, Camden L.;
    • Ruan, Gordon J.;
    • Hathcock, Matthew A.;
    • Abeykoon, Jithma P.;
    • Heimgartner, Joy R.;
    • Baumann, Nikola A.;
    • McMahon, M. Molly;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Bisneto, Jose C. Villasboas;
    • Porrata, Luis F.;
    • Paludo, Jonas;
    • Ansell, Stephen M.;
    • Hogan, William J.;
    • Witzig, Thomas E.
    Publication type:
    Article
    22
    23

    Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
    By:
    • Krull, Jordan E.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Manske, Michelle K.;
    • Sarangi, Vivekananda;
    • Maurer, Matthew J.;
    • Larson, Melissa C.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • McPhail, Ellen;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • King, Rebecca L.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    24
    25

    Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
    By:
    • Wang, Yucai;
    • Wenzl, Kerstin;
    • Manske, Michelle K.;
    • Asmann, Yan W.;
    • Sarangi, Vivekananda;
    • Greipp, Patricia T.;
    • Krull, Jordan E.;
    • Hartert, Keenan;
    • He, Rong;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Slager, Susan L.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    26
    27

    Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 3, p. 389, doi. 10.1080/10428194.2023.2285236
    By:
    • Chohan, Karan L.;
    • Bansal, Radhika;
    • Hathcock, Matthew A.;
    • Paludo, Jonas;
    • Bennani, Nora N.;
    • Johnston, Patrick B.;
    • Khurana, Arushi;
    • Durani, Urshila;
    • Wang, Yucai;
    • Ruff, Michael W.;
    • Villasboas Bisneto, Jose C.;
    • Ansell, Stephen M.;
    • Lin, Yi;
    • Kenderian, Saad S.
    Publication type:
    Article
    28
    29

    Central nervous system involvement by mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 371, doi. 10.1080/10428194.2022.2148211
    By:
    • McLaughlin, Nicole;
    • Wang, Yucai;
    • Witzig, Thomas;
    • Villasboas, Jose;
    • Habermann, Thomas;
    • Inwards, David;
    • Bennani, Nora;
    • Thanarajasingam, Gita;
    • Nowakowski, Grzegorz;
    • Porrata, Luis;
    • Thompson, Carrie;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Ansell, Stephen;
    • Paludo, Jonas
    Publication type:
    Article
    30
    31
    32
    33
    34

    Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 6, p. 1363, doi. 10.1080/10428194.2022.2030475
    By:
    • Melody, Megan;
    • Gandhi, Sangeetha;
    • Saunders, Hollie;
    • Abdel-Rahman, Zaid;
    • Hastings, Jacquelyn;
    • Lengerke Diaz, Paula;
    • Gannon, Nicole;
    • Truong, Tuan;
    • Hathcock, Matthew;
    • Khurana, Arushi;
    • Johnston, Patrick;
    • Ansell, Stephen;
    • Bennani, Nora;
    • Paludo, Jonas;
    • Bisneto, Jose Villasboas;
    • Wang, Yucai;
    • Rosenthal, Allison;
    • Foran, James;
    • Ayala, Ernesto;
    • Murthy, Hemant S.
    Publication type:
    Article
    35
    36
    37
    38

    Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 308, doi. 10.1080/10428194.2020.1832669
    By:
    • Gunaratne, Madugodaralalage D. S. K.;
    • Sahakian, Alexander J.;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kapoor, Prashant;
    • Paulus, Aneel;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Novak, Anne J.;
    • Lacy, Martha Q.;
    • Kyle, Robert A.;
    • Go, Ronald S.;
    • Paludo, Jonas
    Publication type:
    Article
    39
    40

    Analysis and impact of a multidisciplinary lymphoma virtual tumor board.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 14, p. 3351, doi. 10.1080/10428194.2020.1817432
    By:
    • Habermann, Thomas M.;
    • Khurana, Arushi;
    • Lentz, Ruth;
    • Schmitz, John J.;
    • von Bormann, Alexander G.;
    • Young, Jason R.;
    • Hunt, Christopher H.;
    • Christofferson, Sara N.;
    • Nowakowski, Grzegorz S.;
    • McCullough, Kristen B.;
    • Horna, Pedro;
    • Wood, Adam J.;
    • Macon, William R.;
    • Kurtin, Paul J.;
    • Lester, Scott C.;
    • Stafford, Scott L.;
    • Chamarthy, Ushrasree;
    • Khan, Faraz;
    • Ansell, Stephen M.;
    • King, Rebecca L.
    Publication type:
    Article
    41

    Predictors of short-term survival in Waldenström Macroglobulinemia.

    Published in:
    2020
    By:
    • Ruan, Gordon;
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie;
    • Go, Ronald S.;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Paludo, Jonas;
    • Thanarajasingam, Gita;
    • Inwards, David J.;
    • Thompson, Carrie A.;
    • Habermann, Thomas M.;
    • Lin, Yi;
    • Nowakowski, Grzegorz S.;
    • Bisneto, Jose C. Villasboas;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Buadi, Francis K.;
    • Dingli, David
    Publication type:
    Letter
    42
    43
    44
    45
    46
    47
    48
    49

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    50